Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 280

1.

Single electron transistors with hydrogen treatment of ALD SiO2 in nanoscale metal-insulator-metal tunnel junctions.

Karbasian G, McConnell MS, Orlov AO, Nazarov AN, Snider GL.

Nanotechnology. 2017 May 26;28(21):215203. doi: 10.1088/1361-6528/aa6c06. Epub 2017 Apr 7.

PMID:
28387213
2.

Desmosine as a biomarker of elastin degradation in COPD: current status and future directions.

Luisetti M, Ma S, Iadarola P, Stone PJ, Viglio S, Casado B, Lin YY, Snider GL, Turino GM.

Eur Respir J. 2008 Nov;32(5):1146-57. doi: 10.1183/09031936.00174807.

3.

A review of the alpha-1 foundation: its formation, impact, and critical success factors.

Walsh JW, Snider GL, Stoller JK.

Respir Care. 2006 May;51(5):526-31.

4.

Induction of the myofibroblast phenotype following elastolytic injury to mouse lung.

Rishikof DC, Lucey EC, Kuang PP, Snider GL, Goldstein RH.

Histochem Cell Biol. 2006 May;125(5):527-34. Epub 2005 Nov 19.

PMID:
16328432
5.

Dependence of field switched ordered arrays of dinuclear mixed-valence complexes on the distance between the redox centers and the size of the counterions.

Qi H, Gupta A, Noll BC, Snider GL, Lu Y, Lent C, Fehlner TP.

J Am Chem Soc. 2005 Nov 2;127(43):15218-27.

PMID:
16248664
6.

[American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency].

Stoller JK, Snider GL, Brantly ML, Fallat RJ, Stockley RA, Turino GM, Konietzko N, Dirksen A, Eden E, Fallat RJ, Luisetti M, Stolk J, Strange C; American Thoracic Society; European Respiratory Society.

Pneumologie. 2005 Jan;59(1):36-68. German. No abstract available.

PMID:
15685488
7.

Exacerbations of chronic obstructive pulmonary disease: should self-management be used?

Snider GL.

Am J Respir Crit Care Med. 2004 Oct 15;170(8):920. No abstract available.

PMID:
15475407
8.

Veterans Administration support for medical research: opinions of the endangered species of physician-scientists.

Zucker S, Crabbe JC, Cooper G 4th, Finkelman F, Largman C, McCarley RW, Rice L, Rubin J, Richardson B, Seil F, Snider GL, Vandenbark AA.

FASEB J. 2004 Oct;18(13):1481-6.

PMID:
15466355
9.

Only cell and molecular biology can lead to an understanding of pathogenesis of lung disease.

Snider GL.

Am J Respir Crit Care Med. 2004 Jul 1;170(1):i-ii. No abstract available.

PMID:
15220131
10.

Politics of fundraising for research.

Snider GL.

Am J Respir Crit Care Med. 2004 Jul 1;170(1):101; author reply 101. No abstract available.

PMID:
15220130
11.
12.
13.

A two-stage shift register for clocked Quantum-Dot Cellular Automata.

Orlov AO, Kummamuru R, Ramasubramaniam R, Lent CS, Bernstein GH, Snider GL.

J Nanosci Nanotechnol. 2002 Jun-Aug;2(3-4):351-5.

PMID:
12908262
14.

Scanning tunneling microscopy and spectroscopy investigations of QCA molecules.

Manimaran M, Snider GL, Lent CS, Sarveswaran V, Lieberman M, Li Z, Fehlner TP.

Ultramicroscopy. 2003 Oct-Nov;97(1-4):55-63.

PMID:
12801657
15.

Retinoic acid does not affect alveolar septation in adult FVB mice with elastase-induced emphysema.

Lucey EC, Goldstein RH, Breuer R, Rexer BN, Ong DE, Snider GL.

Respiration. 2003 Mar-Apr;70(2):200-5.

PMID:
12740518
16.

Understanding inflammation in chronic obstructive pulmonary disease: the process begins.

Snider GL.

Am J Respir Crit Care Med. 2003 Apr 15;167(8):1045-6. No abstract available.

PMID:
12684241
17.

Nosology for our day: its application to chronic obstructive pulmonary disease.

Snider GL.

Am J Respir Crit Care Med. 2003 Mar 1;167(5):678-83. No abstract available.

PMID:
12598211
18.
19.

Urinary desmosine excretion in acute exacerbations of COPD: a preliminary report.

Fiorenza D, Viglio S, Lupi A, Baccheschi J, Tinelli C, Trisolini R, Iadarola R, Luisetti M, Snider GL.

Respir Med. 2002 Feb;96(2):110-4.

20.

Severity of elastase-induced emphysema is decreased in tumor necrosis factor-alpha and interleukin-1beta receptor-deficient mice.

Lucey EC, Keane J, Kuang PP, Snider GL, Goldstein RH.

Lab Invest. 2002 Jan;82(1):79-85.

PMID:
11796828
21.

Limitations of randomized clinical trials for evaluating emerging operations: the case of lung volume reduction surgery.

Berger RL, Celli BR, Meneghetti AL, Bagley PH, Wright CD, Ingenito EP, Gray A, Snider GL.

Ann Thorac Surg. 2001 Aug;72(2):649-57. Review.

PMID:
11515928
22.

XAFS and X-ray reflectivity study of III-V compound native oxide/GaAs interfaces.

Cheong SK, Bunker BA, Hall DC, Snider GL, Barrios PJ.

J Synchrotron Radiat. 2001 Mar 1;8(Pt 2):824-6.

PMID:
11512945
23.

Chest computed tomography: is it ready for major studies of chronic obstructive pulmonary disease?

Cosio MG, Snider GL.

Eur Respir J. 2001 Jun;17(6):1062-4. No abstract available.

24.

Short-term supplementation therapy does not affect elastin degradation in severe alpha(1)-antitrypsin deficiency. The American-Italian AATD Study Group.

Gottlieb DJ, Luisetti M, Stone PJ, Allegra L, Cantey-Kiser JM, Grassi C, Snider GL.

Am J Respir Crit Care Med. 2000 Dec;162(6):2069-72.

PMID:
11112116
25.

Partially suppressed shot noise in hopping conduction: observation in SiGe quantum wells

Kuznetsov VV, Mendez EE, Zuo X, Snider GL, Croke ET.

Phys Rev Lett. 2000 Jul 10;85(2):397-400.

PMID:
10991292
26.

Electric razors as a potential vector for viral hepatitis.

Arbeit RD, Goodman RP, Snider GL.

N Engl J Med. 2000 Jun 15;342(24):1840-1. No abstract available.

28.

Digital logic gate using quantum-Dot cellular automata

Amlani I I, Orlov AO, Toth G, Bernstein GH, Lent CS, Snider GL.

Science. 1999 Apr 9;284(5412):289-91.

29.

[Risk factors and populations at risk].

Snider GL.

Rev Mal Respir. 1998 Sep;15 Suppl 2:S5-9. French. No abstract available.

PMID:
9809335
30.

Remodeling of alveolar walls after elastase treatment of hamsters. Results of elastin and collagen mRNA in situ hybridization.

Lucey EC, Goldstein RH, Stone PJ, Snider GL.

Am J Respir Crit Care Med. 1998 Aug;158(2):555-64.

PMID:
9700135
31.

Distribution of elastin in hamsters and the turnover rates of different elastin pools.

Stone PJ, Lucey EC, Snider GL, Franzblau C.

Proc Soc Exp Biol Med. 1997 May;215(1):94-101.

PMID:
9142143
32.

Tuberculosis then and now: a personal perspective on the last 50 years.

Snider GL.

Ann Intern Med. 1997 Feb 1;126(3):237-43.

PMID:
9027277
33.

Urinary desmosine excretion in smokers with and without rapid decline of lung function: the Normative Aging Study.

Gottlieb DJ, Stone PJ, Sparrow D, Gale ME, Weiss ST, Snider GL, O'Connor GT.

Am J Respir Crit Care Med. 1996 Nov;154(5):1290-5.

PMID:
8912738
34.

A trial of increased access to primary care.

Snider GL, Colucci WS, Sawin CT.

N Engl J Med. 1996 Sep 19;335(12):896; author reply 897-8. No abstract available.

PMID:
8778618
35.

Health care technology assessment of surgical procedures.

Snider GL.

Am J Respir Crit Care Med. 1996 Sep;154(3 Pt 1):824. No abstract available.

PMID:
8810627
36.
38.

Differential expression of elastin and alpha 1(I) collagen mRNA in mice with bleomycin-induced pulmonary fibrosis.

Lucey EC, Ngo HQ, Agarwal A, Smith BD, Snider GL, Goldstein RH.

Lab Invest. 1996 Jan;74(1):12-20.

PMID:
8569173
39.

Elastin and collagen degradation products in urine of patients with cystic fibrosis.

Stone PJ, Konstan MW, Berger M, Dorkin HL, Franzblau C, Snider GL.

Am J Respir Crit Care Med. 1995 Jul;152(1):157-62.

PMID:
7599816
40.

Cross-linked elastin and collagen degradation products in the urine of patients with scleroderma.

Stone PJ, Korn JH, North H, Lally EV, Miller LC, Tucker LB, Strongwater S, Snider GL, Franzblau C.

Arthritis Rheum. 1995 Apr;38(4):517-24.

PMID:
7718005
41.

Elastin and collagen degradation products in urine of smokers with and without chronic obstructive pulmonary disease.

Stone PJ, Gottlieb DJ, O'Connor GT, Ciccolella DE, Breuer R, Bryan-Rhadfi J, Shaw HA, Franzblau C, Snider GL.

Am J Respir Crit Care Med. 1995 Apr;151(4):952-9.

PMID:
7697272
42.

Withholding and withdrawing life-sustaining therapy: all systems are not yet "go"

Snider GL.

Am J Respir Crit Care Med. 1995 Feb;151(2):279-81. No abstract available.

PMID:
11654310
43.

Withholding and withdrawing life-sustaining therapy. All systems are not yet "go".

Snider GL.

Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):279-81. No abstract available.

PMID:
7842179
44.
45.
46.

Molecular epidemiology: a key to better understanding of chronic obstructive lung disease.

Snider GL.

Monaldi Arch Chest Dis. 1995 Jan;50(1):3-6. No abstract available.

PMID:
7538006
47.

Pitfalls in antiprotease therapy of emphysema.

Snider GL, Lucey EC, Stone PJ.

Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 2):S131-7. Review.

PMID:
7952648
48.

Allocation of intensive care. The physician's role.

Snider GL.

Am J Respir Crit Care Med. 1994 Aug;150(2):575-80. No abstract available.

PMID:
8049851
49.

Pathogenesis and terminology of emphysema.

Snider GL.

Am J Respir Crit Care Med. 1994 May;149(5):1382-3. No abstract available.

PMID:
8173782
50.

Perivascular fibrosis of muscular pulmonary arteries in COPD.

Snider GL.

Chest. 1994 Mar;105(3):973-4. No abstract available.

PMID:
8131590

Supplemental Content

Loading ...
Support Center